CT vs MRI: Choosing the Right Tool

Few decisions shape a neurologic workup more than which scanner the patient enters first. CT and MRI are not competitors but complementary instruments, each tuned to a different physical question. CT asks, "How much does this tissue stop an X-ray beam?" MRI asks, "How do hydrogen protons in this tissue behave in a magnetic field?" Knowing which question to ask — and when — separates an efficient workup from a delayed diagnosis. This page walks through the physics, the strengths and blind spots of each modality, and the practical decision points you face at the bedside, in the ED, and on the stroke service.

How CT works: Hounsfield units and X-ray attenuation

Computed tomography reconstructs cross-sectional images from the differential attenuation of X-rays as they pass through tissue. Attenuation is quantified on the Hounsfield unit (HU) scale, calibrated so that water measures 0 HU. The scale spans from strongly negative values for low-density material to high positive values for dense material:

• Air: very negative (≈ −1000 HU)
• Fat: negative (roughly −50 to −100 HU)
• Water and CSF: near 0 HU
• Acute blood: hyperdense, approximately 50–100 HU — the basis for spotting fresh hemorrhage
• Bone and calcification: very high (several hundred to over 1000 HU)

Because the data are acquired in seconds and scanners are nearly universal, CT is fast, ubiquitous, and inexpensive — qualities that matter enormously when the clock is running.

What CT does best — and where it falls short

CT excels precisely where speed and density discrimination count most:

• Acute hemorrhage: fresh blood is reliably hyperdense, making non-contrast CT the workhorse for detecting intracranial hemorrhage.
• Bone and fracture: the high attenuation of cortical bone makes CT the modality of choice for skull and facial fractures.
• Calcification: easily identified, useful for characterizing lesions and detecting vascular or tumoral calcification.

These strengths explain why a non-contrast head CT is the first-line study in acute stroke — its job is to exclude hemorrhage before thrombolysis — and the front-line tool in head trauma. Its limitations are equally important to keep in mind:

• Limited early ischemia detection: the parenchymal changes of infarction are subtle for the first several hours.
• Poor posterior fossa visualization: beam-hardening artifact from the dense skull base degrades imaging of the brainstem and cerebellum.
• Ionizing radiation and the risks of iodinated contrast (allergic-type reactions and contrast-associated nephropathy in vulnerable patients).

Early CT signs of ischemia

Although frank hypodensity from a completed infarct evolves over hours to days, several subtle early signs can be detected within the first hours and should be hunted deliberately:

• Loss of gray–white differentiation as cytotoxic edema blurs the normally crisp cortical interface
• Insular ribbon sign — loss of the normal insular cortex definition
• Obscured lentiform nucleus — effacement of the basal ganglia margins
• Sulcal effacement from early swelling
• Hyperdense MCA sign — a visible intraluminal thrombus appearing as a dense artery

Pearl: a hyperdense MCA is a sign of clot, not blood in the brain — don't mistake it for hemorrhage. It signals a large-vessel occlusion worth pursuing with CT angiography.

How MRI works and what it does best

MRI uses strong magnetic fields and radiofrequency pulses to manipulate and read out signal from hydrogen protons. It uses no ionizing radiation and delivers far superior soft-tissue contrast than CT. Its decisive advantages in neurology include:

• Diffusion-weighted imaging (DWI): detects acute ischemia within minutes of onset. Restricted diffusion appears bright on DWI with a corresponding dark ADC — far earlier and more sensitive than CT.
• Posterior fossa: the brainstem and cerebellum are imaged without the beam-hardening artifact that hampers CT.
• Demyelination, tumors, encephalitis, and small lesions: superior contrast resolution reveals pathology CT may miss entirely, making MRI the modality of choice for multiple sclerosis and many inflammatory and neoplastic processes.
• Gadolinium enhancement marks breakdown of the blood–brain barrier, highlighting tumor, inflammation, and infection.

MRI's trade-offs are real: it is slower, costlier, and less available; it is sensitive to patient motion; and it carries contraindications including certain pacemakers and implanted devices and retained ferromagnetic metal. Gadolinium warrants caution in severe renal impairment.

Putting it together: a practical workflow

The two modalities slot into a logical sequence:

• Acute stroke, trauma, or sudden severe ("thunderclap") headache → non-contrast CT first, to rapidly exclude hemorrhage.
• Then MRI (with MRA as needed) to characterize ischemia, evaluate the posterior fossa, or work up a non-diagnostic CT.
• Vessels and tissue viability: CT angiography and CT perfusion, or MR angiography and MR perfusion, define the occluded vessel and the salvageable penumbra to guide reperfusion decisions.

Pearl: "CT to rule out blood and bone, MRI to see the brain" is a fair mnemonic — but never let an MRI delay treatment when a fast CT answers the urgent question.